Rafael Santos

Rafael Santos

Auto-generated profile, based on publicly available information

Rafael Santos

I3S–Instituto de Investigação e Inovação em Saúde Universidade do Porto Porto Portugal

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
ASAna Spencer
Ana Spencer
AVAdriana Vilaça
Adriana Vilaça
Miguel XavierMiguel Xavier
Miguel Xavier
RSRafael Santos
Rafael Santos
AIAriel Ionescu
Ariel Ionescu
APAna Paula Pêgo
Ana Paula Pêgo
Gene therapy using small interfering RNA (siRNA) holds promise for treating neurological disorders by silencing specific genes, like the phosphatase and tensin homolog (PTEN) gene, which restricts axonal growth. Effective siRNA delivery to neurons, however, poses challenges due to premature nucleic acid degradation and unspecific delivery. Chitosan‐based delivery systems, noted for their biocompatibility, face limitations such as low transfection efficiency and lack of neurotropism. Building on the previous successes with neuron‐targeted DNA delivery using chitosan, a novel approach for siRNA delivery aimed at PTEN downregulation is proposed. This involves using thiolated trimethyl chitosan (TMCSH)–based siRNA nanoparticles functionalized with the neurotropic C‐terminal fragment of the tetanus neurotoxin heavy chain (HC) for efficient delivery to peripheral and central neurons. These polyplexes demonstrate suitable physicochemical properties, biocompatibility, and no adverse effects on neuronal electrophysiology. Diverse neuronal models, including 3D ex vivo cultures and microfluidics, confirm the polyplexes’ efficiency and neurospecificity. HC‐functionalization significantly enhances neuronal binding, and live cell imaging reveals fivefold faster retrograde transport along axons. Furthermore, siRNA delivery targeting PTEN promoted axonal outgrowth in embryonic cortical neurons. In conclusion, the proposed polyplexes represent a promising platform for neuronal siRNA delivery, offering potential for clinical translation and therapeutic applications.

10 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAna Spencer
Ana Spencer
AVAdriana Vilaça
Adriana Vilaça
Miguel XavierMiguel Xavier
Miguel Xavier
RSRafael Santos
Rafael Santos
AIAriel Ionescu
Ariel Ionescu
APAna Paula Pêgo
Ana Paula Pêgo
Gene therapy using small interfering RNA (siRNA) holds promise for treating neurological disorders by silencing specific genes, such as the phosphatase and tensin homolog ( PTEN ) gene, which restricts axonal growth. Yet, delivering siRNA to neurons efficiently is challenging due to premature degradation and unspecific delivery. Chitosan-based delivery systems have shown great potential due to their well-established biocompatibility. However, their limited transfection efficiency and lack of neuronal tropism require further modification. Building on our previous successes with neuron-targeted DNA delivery using chitosan, a novel approach for siRNA delivery aimed at PTEN downregulation is proposed. This involves using thiolated trimethyl chitosan (TMCSH)-based siRNA nanoparticles functionalized with the neurotropic C-terminal fragment of the tetanus neurotoxin heavy chain (HC) for efficient delivery to both peripheral and central neurons. These polyplexes demonstrated suitable physicochemical properties, biocompatibility, and no adverse effects on neuronal electrophysiology. Diverse neuronal models, including 3D ex vivo cultures and microfluidics, confirmed polyplexes’ efficiency and neurospecificity. HC targeting significantly enhanced nanoparticle neuronal binding, and live cell imaging revealed five times faster retrograde transport along axons. Furthermore, siRNA delivery targeting PTEN promoted axonal outgrowth in embryonic cortical neurons. Thus, these polyplexes represent a promising platform for siRNA delivery, offering potential for clinical translation and therapeutic applications.

10 September 2024 in bioRxiv
Verified
Preprint
Open access
ASAna Spencer
Ana Spencer
Miguel XavierMiguel Xavier
Miguel Xavier
SGSofia C. Guimaraes
Sofia C. Guimaraes
AVAdriana Vilaça
Adriana Vilaça
AIAriel Ionescu
Ariel Ionescu
APAna Paula Pêgo
Ana Paula Pêgo
Neurological disorders, a leading global cause of death, encompass conditions affecting the peripheral and central nervous systems (PNS and CNS, respectively). Limited axon regeneration is a significant challenge in these disorders, and it is linked to proteins like PTEN. RNA-based therapeutics, particularly siRNAs, hold potential for silencing these inhibitory pathways, but their clinical application is hindered by poor stability and cellular uptake. Our study addressed this challenge with the development of novel, fully biodegradable dendritic nanoparticles designed specifically for neuron targeting. These nanoparticles were functionalized with the neurotropic binding domain of tetanus toxin, enhancing selective neuronal targeting and cellular internalization. We demonstrated that these dendriplexes not only maintain biocompatibility and efficient siRNA delivery in neuronal cultures but also significantly enhance axonal growth, as shown in microfluidic models. In a groundbreaking PNS-CNS-on-Chip, dendriplexes exhibited effective migration from PNS to CNS neurons, highlighting their potential for targeted therapeutic delivery. This study pioneers the application of microfluidics to demonstrate the CNS targeting of dendriplexes, paving the way for innovative treatments in the field of nanomedicine.

1 January 2022 in Anais Qualihosp
Verified
Conference Paper
Closed access
MPMarcius Conceição Prestes
Marcius Conceição Prestes
RSRafael Borges dos Santos
Rafael Borges dos Santos
TFTiane Muriel Volpato Prado Farias
Tiane Muriel Volpato Prado Farias
MXMara Paula Gomes Xavier
Mara Paula Gomes Xavier
ANAline Lucas Nunes
Aline Lucas Nunes
Anais Qualihosp (2316-9419) - Melhorando O Fluxo Do Paciente Através Da Redução Do Tempo De Desocupação De Leitos Em Unidade De Internação